本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Rapport Therapeutics, Inc.

44.46
+0.83501.91%
成交量:6.86萬
成交額:303.61萬
市值:21.33億
市盈率:-14.56
高:44.90
開:44.30
低:43.36
收:43.62
52周最高:52.93
52周最低:22.73
股本:4,797.83萬
流通股本:3,039.38萬
量比:0.36
換手率:0.23%
股息:- -
股息率:- -
每股收益(TTM):-3.0525
每股收益(LYR):-2.8633
淨資產收益率:-39.96%
總資產收益率:-25.78%
市淨率:5.04
市盈率(LYR):-15.53

資料載入中...

2026/08/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/12

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/05

重要事件披露

Form 8-K - Current report
2026/07/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/10

重要事件披露

Form 8-K - Current report
2026/05/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/07

重要事件披露

Form 8-K - Current report
2026/04/21

重要事件披露

Form 8-K - Current report
2026/04/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities